Cargando…

Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease.

Monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) was tested in 23 patients with histologically proven Hodgkin's disease and 29 healthy normal controls. Seven patients presented with active and 16 with inactive disease. The lytic capacity of the individual monocytes was signific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pehamberger, H., Ludwig, H., Pötzi, P., Knapp, W.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1980
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010310/ https://www.ncbi.nlm.nih.gov/pubmed/7426302

Ejemplares similares

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
por: Mielke, Dieter, et al.
Publicado: (2019)

Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC)
por: Jäpel, M., et al.
Publicado: (1994)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
por: Khanna, Vidhi, et al.
Publicado: (2021)

Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] Responses
por: Pollara, Justin, et al.
Publicado: (2013)

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART)
por: Jensen, Sanne Skov, et al.
Publicado: (2015)

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells
por: Delaporte, M, et al.
Publicado: (2009)

Using impedance-based approaches for measuring cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC)
por: Lamarche, Brandon, et al.
Publicado: (2015)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
por: Parsons, MS, et al.
Publicado: (2012)

Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
por: Fenerty, Kathleen E., et al.
Publicado: (2018)

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
por: Iida, Shigeru, et al.
Publicado: (2009)

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma
por: Tso, For Yue, et al.
Publicado: (2021)

Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
por: Fenerty, Kathleen E., et al.
Publicado: (2019)

Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1
por: Ernst, Daniel, et al.
Publicado: (2019)

The Yin and Yang of ADCC-Mediating Antibodies
por: Robert-Guroff, Marjorie
Publicado: (2016)

Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
por: Aziz, Mariam, et al.
Publicado: (2015)

Critical role for monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity
por: Kramski, M, et al.
Publicado: (2012)

The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein
por: Chen, Xuemin, et al.
Publicado: (2021)

Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement
por: Kline, James Bradford, et al.
Publicado: (2017)

The Contribution of IgG Glycosylation to Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC) in Hashimoto’s Thyroiditis: An in Vitro Model of Thyroid Autoimmunity
por: Ząbczyńska, Marta, et al.
Publicado: (2020)

Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
por: Tang, Jennifer J.-J., et al.
Publicado: (2020)

A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies
por: Orlandi, Chiara, et al.
Publicado: (2016)

High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19
por: Vietzen, Hannes, et al.
Publicado: (2022)

CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes
por: Yeap, Wei Hseun, et al.
Publicado: (2016)

Corrigendum: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes
por: Yeap, Wei Hseun, et al.
Publicado: (2017)

Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
por: Yucha, Ryan, et al.
Publicado: (2023)

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells
por: Simhadri, Venkateswara R., et al.
Publicado: (2015)

Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
por: Termini, James M., et al.
Publicado: (2020)

Antibody–receptor interactions mediate antibody-dependent cellular cytotoxicity
por: Sun, Yue, et al.
Publicado: (2021)

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes
por: Pollara, J, et al.
Publicado: (2012)

FcgRIIIA (CD16)-expressing monocytes mediate the depletion of tumor-infiltrating Tregs via Ipilimumab-dependent ADCC in melanoma patients
por: Romano, Emanuela, et al.
Publicado: (2014)

Influenza and Antibody-Dependent Cellular Cytotoxicity
por: Von Holle, Tarra A., et al.
Publicado: (2019)

NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy
por: Wang, Wei, et al.
Publicado: (2015)

ADCC potency assay: increased standardization with modified lymphocytes
por: Bretaudeau, Laurent, et al.
Publicado: (2011)

A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies
por: Lallemand, Christophe, et al.
Publicado: (2017)

1008. Presence of Antibody Dependent Cell Cytotoxicity (ADCC) Functional Antibodies that Target a Complex Gp41 Epitope Correlates with Long-term Non-progression and ADCC is Maintained with Mutants Using Germline Heavy Chain Variable Gene Sequence of VH1-02 Gene
por: Baron, Sarah, et al.
Publicado: (2021)

ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
por: Semmes, Eleanor C., et al.
Publicado: (2023)

Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
por: Seidel, Ursula J. E., et al.
Publicado: (2013)

Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
por: Wang, Zhaoming, et al.
Publicado: (2021)

Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity
por: Kwok, Hang Fai, et al.
Publicado: (2011)

Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC
por: Natsume, Akito, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_p9jou655av2tcs8shm4iq7flq8